{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:26:12Z","timestamp":1791563172291,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Non-invasive prenatal screening (NIPS) <jats:italic>via<\/jats:italic> cell-free DNA (cfDNA) screens for fetal chromosome disorders using maternal plasma, including 22q11.2 deletion syndrome (22q11.2DS). While it is the commonest microdeletion syndrome and has potential implications for perinatal management, prenatal screening for 22q11.2DS carries some inherent technical, biological, and counseling challenges, including varying deletion sizes\/locations, maternal 22q11.2 deletions, confirmatory test choice, and variable phenotype.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> This study addresses these considerations utilizing a retrospective cohort of 307 samples with screen-positive 22q11.2 NIPS results on a massively parallel sequencing (MPS) platform.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Approximately half of the cases reported ultrasound findings at some point during pregnancy. In 63.2% of cases with diagnostic testing, observed positive predictive values were 90.7%\u201399.4%. cfDNA identified deletions ranging from &amp;lt;1\u00a0Mb to 3.55\u00a0Mb, with significant differences in confirmed fetal <jats:italic>versus<\/jats:italic> maternal deletion sizes; estimated cfDNA deletion size was highly concordant with microarray findings. Mosaicism ratio proved useful in predicting the origin of a deletion (fetal <jats:italic>versus<\/jats:italic> maternal). Prediction of deletion size, location, and origin may help guide confirmatory testing.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> The data shows that MPS-based NIPS can screen for 22q11.2DS with a high PPV, and that collaboration between the laboratory and clinicians allows consideration of additional metrics that may guide diagnostic testing and subsequent management.<\/jats:p>","DOI":"10.3389\/fgene.2023.1146669","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T04:28:49Z","timestamp":1678422529000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Positive cfDNA screening results for 22q11.2 deletion syndrome\u2014Clinical and laboratory considerations"],"prefix":"10.3389","volume":"14","author":[{"given":"Erica","family":"Soster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Dyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Rafalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Cacheris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice Bulletin, number 226","volume":"136","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","article-title":"Practical guidelines for managing patients with 22q11.2 deletion syndrome","volume":"159","author":"Bassett","year":"2011","journal-title":"J. Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/uog.23699","article-title":"Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort","volume":"58","author":"Bevilacqua","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/ajmg.a.40637","article-title":"What is new with 22q? An update from the 22q and you center at the Children's hospital of philadelphia","volume":"176","author":"Campbell","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/gim.2013.71","article-title":"Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome","volume":"16","author":"Cheung","year":"2014","journal-title":"Genet. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"79.e1","DOI":"10.1016\/j.ajog.2022.01.002","article-title":"Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome","volume":"227","author":"Dar","year":"2022","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.gim.2022.11.004","article-title":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Dungan","year":"2022","journal-title":"Genet. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/gim.2014.175","article-title":"Practical guidelines for managing adults with 22q11.2 deletion syndrome","volume":"17","author":"Fung","year":"2015","journal-title":"Genet. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/uog.15754","article-title":"Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome","volume":"47","author":"Gross","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/pd.4640","article-title":"Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing","volume":"35","author":"Helgeson","year":"2015","journal-title":"Prenat. Diagn"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100334","DOI":"10.1016\/j.gim.2022.10.014","article-title":"Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions","volume":"25","author":"Hoskovec","year":"2022","journal-title":"Genet. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e57381","DOI":"10.1371\/journal.pone.0057381","article-title":"High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma","volume":"8","author":"Jensen","year":"2013","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"227e1","DOI":"10.1016\/j.ajog.2016.02.030","article-title":"Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants","volume":"215","author":"Lefkowitz","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41436-019-0467-4","article-title":"Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes","volume":"21","author":"Liang","year":"2019","journal-title":"Genet. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/uog.8895","article-title":"Prenatal ultrasound screening for orofacial clefts","volume":"38","author":"Maarse","year":"2011","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.13098","article-title":"Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions","volume":"93","author":"Martin","year":"2018","journal-title":"Clin. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/ajmg.a.40653","article-title":"22q11.2 deletion syndrome: A tiny piece leading to a big picture","volume":"176","author":"McDonald-McGinn","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"B18","article-title":"22q11.2 deletion syndrome","volume-title":"GeneReviews\u00ae [internet]","author":"McDonald-McGinn","year":"1999"},{"key":"B19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00125817-200101000-00006","article-title":"Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net","volume":"3","author":"McDonald-Mcginn","year":"2001","journal-title":"Genet. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/uog.23756","article-title":"Clinical experience with non\u2010invasive prenatal screening for single\u2010gene disorders","volume":"59","author":"Mohan","year":"2022","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/AOG.0000000000001405","article-title":"Practice Bulletin No 162: Prenatal diagnostic testing for genetic disorders","volume":"127","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41436-021-01227-5","article-title":"Genome-wide cell-free DNA screening: A focus on copy-number variants","volume":"23","author":"Rafalko","year":"2021","journal-title":"Genet. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/pd.5863","article-title":"Impact of mosaicism ratio on positive predictive value of cfDNA screening","volume":"41","author":"Rafalko","year":"2021","journal-title":"Prenat. Diagn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.gim.2022.07.002","article-title":"Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","volume":"24","author":"Rose","year":"2022","journal-title":"Genet. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41436-021-01135-8","article-title":"Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants","volume":"23","author":"Soster","year":"2021","journal-title":"Genet. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in The Netherlands","volume":"105","author":"van der Meij","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/gim.2015.84","article-title":"Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome","volume":"18","author":"Van","year":"2016","journal-title":"Genet. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/gim.2017.132","article-title":"Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: Results of the TRIDENT study","volume":"20","author":"Van Opstal","year":"2018","journal-title":"Genet. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12920-021-01131-6","article-title":"Expanding the application of non-invasive prenatal testing in the detection of foetal chromosomal copy number variations","volume":"14","author":"Wang","year":"2021","journal-title":"BMC Med. Genomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41591-018-0334-x","article-title":"Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA","volume":"25","author":"Zhang","year":"2019","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1373\/clinchem.2014.233312","article-title":"Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma","volume":"61","author":"Zhao","year":"2015","journal-title":"Clin. Chem."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1146669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T04:28:53Z","timestamp":1678422533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1146669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":32,"alternative-id":["10.3389\/fgene.2023.1146669"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1146669","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1146669"}}